safingol has been researched along with Tuberculosis, Drug-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves Pereira, VR; Carneiro Neves, MM; Correia de Sousa, LA; da Silva Santos, AC; de la Vega, J; Dos Santos Peixoto, A; Ferreira, LFGR; Hernandes, MZ; Linhares, LA; Lucena Laet, JP; Montenegro, LML; Olmo, ED; Pereira-Neves, A; San Feliciano, A; Schindler, HC | 1 |
| Alves, M; Del Olmo, E; Escarcena, R; Feliciano, AS; Hernandez-Pando, R; López-Pérez, JL; Molina-Salinas, GM; Said-Fernández, S | 1 |
2 other study(ies) available for safingol and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Sphingosine; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2023 |
Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sphingosine; Tuberculosis, Multidrug-Resistant | 2009 |